Corundum Neuroscience Overview
Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The CNS team combines deep domain expertise with a track-record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people's health, longevity and happiness. Corundum Neuroscience operates under parent company Corundum Innovation, a Japanese-based investment firm providing comprehensive support through research funding, venture investment services and new business consulting.
Latest News
growth-positive
Offline Studio Partners with Corundum Neuroscience and Corundum Systems Biology for New Life Sciences Venture Creation
Corundum Neuroscience (CNS) and Corundum Systems Biology (CSB) have partnered with Offline Studio to launch a new venture creation initiative. This initiative aims to leverage data from the Human Phenotype Project to develop life sciences products that enhance human wellbeing. Both CNS and CSB, alongside Offline Studio, will initially commit $1 million each, with an additional $1.5 million reserved for later stages. The initiative will focus on using AI to derive insights from health data, with Offline Studio leading the venture creation process. This collaboration is expected to bring impactful health solutions to market, with a structured process for project identification, validation, and company formation.
PartnersInvestment
growth-positive
/PRNewswire/ -- Corundum Neuroscience, a leading neuroscience venture builder and fund, today announced it has awarded a research grant for a project led by...
Corundum Neuroscience has awarded a research grant for a project led by Professor Asya Rolls at Tel Aviv University. The project aims to map brain areas suitable for neuromodulation to develop therapies for autoimmune and inflammatory diseases. The study will use viral tracing techniques to explore brain regions roles in immune regulation and identify potential therapeutic targets. The research could lead to novel non-invasive treatments for conditions like Crohns disease and multiple sclerosis. Corundum Neuroscience, a venture builder in neuroscience, supports this initiative through Ramot, Tel Aviv Universitys tech transfer company.
Partners
growth-positive
/PRNewswire/ -- Corundum Neuroscience (CNS), the neuroscience venture builder and fund, and Corundum Systems Biology (CSB), a leading investor in life-changing...
Corundum Neuroscience and Corundum Systems Biology are hosting panel sessions at the inaugural SXSW London in June 2025. The discussions will focus on the role of sleep innovation for brain health and the influence of the microbiome on human well-being. The panels will explore how microbiome science is reshaping drug development and personalized health interventions, as well as how sleep technology is unlocking human potential by enhancing cognitive health and enabling early detection of neurodegenerative diseases. These sessions highlight the companies commitment to advancing transformative neuroscience and systems biology solutions.
Growth-Positive
Joy Ventures Rebrands as Corundum Neuroscience, Launching New Venture Builder and Fund to Spur Neuroscience Technology Innovation
Corundum Neuroscience, formerly Joy Ventures, has launched a new neuroscience-focused venture builder and fund to spur neuroscience research and innovation. The company works with researchers and entrepreneurs to build and grow companies developing innovative solutions in various health and disease areas. The companys lab-to-life model supports the entire innovation journey, from research and concept to commercialization. The rebranding signifies the companys focus on facilitating greater neuroscience research and innovation. Corundum Neuroscience operates under parent company Corundum Innovation, a Japanese-based investment firm.
InvestmentRebrandingExpand
growth-positive
Goodbye cybersecurity, hello CalmTech: How Israeli tech is transforming mental wellness
The article discusses the growing importance of mental wellbeing and the role of tech startups in this space. It highlights the increasing consumer demand for stress-relief and wellness solutions, and the subsequent rise in institutional investment in mental wellbeing tech. The article mentions several startups that are developing innovative solutions in this space, including Reflect Innovation, Wisdo, and Myndlift. It also discusses the shift in the healthcare market towards preventative care and the rise of employee wellbeing. The article is written by Miri Polachek, CEO of Joy Ventures, a fund dedicated to building, funding, and supporting consumer wellbeing startups.
InvestmentCustomersPartners
Team Members
6
Web & Social Links
| Website | cnsfund.com |
Locations
Ha-Menofim Street 11, Herzliya, Israel
Photos & Videos
No files yet
